Featured Research

from universities, journals, and other organizations

Craniosynostosis: Minimally Invasive Surgery Holds Promise For Premature Skull Fusion

Date:
February 18, 2008
Source:
University of Missouri-Columbia
Summary:
Craniosynostosis, the premature fusion of the skull, is estimated to affect one out of every 2,000 babies. For the past several years, physicians have used two procedures to correct the problems. Now, the first long-term study has found that a minimally invasive technique is just as effective and results in a quicker recovery time than the old technique.

Craniosynostosis, the premature fusion of the skull, is estimated to affect one out of every 2,000 babies. For the past several years, physicians have used two procedures to correct the problems. One procedure was to make an incision from ear to ear, strip back the scalp of the infant and reshape the skull by breaking the bones that had fused. The other procedure required a small incision near the point of the fused skull plates. Now, the first long-term study by a researcher at the University of Missouri School of Medicine found that the minimally invasive technique is just as effective and results in a quicker recovery time than the old technique.

With craniosynostosis, two or more of the five skull plates fuse prematurely, restricting growth in the head for the brain. As the brain expands, the fused skull plates put pressure on the brain and can cause facial and skull deformities and, in some cases, brain damage.

Because the brain grows the fastest from birth to six months, it is ideal if surgeons can correct the problem as early as possible. Because of the massive amount of blood loss associated with the old technique, surgeons could not operate until the infants were between nine months and one year old. Because the new technique involves only a very small amount of blood loss, surgeons have been able to perform the surgery on babies as young as one month old.

"Instead of exposing the skull as surgeons do with the old technique, we are able to make two small incisions and remove a small strip of bone," said Usiakimi Igbaseimokumo, assistant professor of neurosurgery. "Our preliminary results in this study indicate that not only is the surgery successful in correcting the problem, but also that the procedure is as, or more, effective than the older procedure in the long term."

The study followed 78 patients who had the procedure in the last 10 years. Preliminary findings of the pilot study indicated the children were developing correctly and had good facial features. Another benefit of the new surgery is the shorter length of time the child has to be in the operating room. The minimally invasive technique only lasts about an hour, while the older technique can last as long as eight hours, Igbaseimokumo said.

Igbaseimokumo, who presented his preliminary findings at a recent meeting of the International Society of Pediatric Neurosurgeons, is will expand his study for another five to 10 years. He will be watching the children's neurological and psychological development, assessing their school reports and examining social and genetic background.

"It's very interesting that despite good results, this minimally invasive technique is not used more by surgeons around the country," Igbaseimokumo said. "We've demonstrated with our preliminary results this technique can correct the problem and help children in their neuropsychological development."


Story Source:

The above story is based on materials provided by University of Missouri-Columbia. Note: Materials may be edited for content and length.


Cite This Page:

University of Missouri-Columbia. "Craniosynostosis: Minimally Invasive Surgery Holds Promise For Premature Skull Fusion." ScienceDaily. ScienceDaily, 18 February 2008. <www.sciencedaily.com/releases/2008/02/080218140424.htm>.
University of Missouri-Columbia. (2008, February 18). Craniosynostosis: Minimally Invasive Surgery Holds Promise For Premature Skull Fusion. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/02/080218140424.htm
University of Missouri-Columbia. "Craniosynostosis: Minimally Invasive Surgery Holds Promise For Premature Skull Fusion." ScienceDaily. www.sciencedaily.com/releases/2008/02/080218140424.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins